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Abstract: AMP-activated protein kinase AMPK regulates cellular energy by controlling metabolism
through the inhibition of anabolic pathways and the simultaneous stimulation of catabolic pathways.
Given its central regulator role in cell metabolism, AMPK activity and its regulation have been the
focus of relevant investigations, although only a few studies have focused on the AMPK function in
the control of spermatozoa’s ability to fertilize. This review summarizes the known cellular roles of
AMPK that have been identified in mammalian spermatozoa. The involvement of AMPK activity is
described in terms of the main physiological functions of mature spermatozoa, particularly in the
regulation of suitable sperm motility adapted to the fluctuating extracellular medium, maintenance
of the integrity of sperm membranes, and the mitochondrial membrane potential. In addition,
the intracellular signaling pathways leading to AMPK activation in mammalian spermatozoa are
reviewed. We also discuss the role of AMPK in assisted reproduction techniques, particularly during
semen cryopreservation and preservation (at 17 ◦C). Finally, we reinforce the idea of AMPK as a key
signaling kinase in spermatozoa that acts as an essential linker/bridge between metabolism energy
and sperm’s ability to fertilize.
Keywords: AMP-activated protein kinase (AMPK); spermatozoa; motility; mitochondria; membranes;
signaling; stress; assisted reproduction techniques
1. Introduction
The AMP-activated protein kinase (AMPK) acts as a sensor molecule of cellular energy charge
that maintains energy homeostasis at both the whole-body and cellular levels [1,2] by controlling key
anabolic and catabolic pathways under different energy or stressful conditions. Thus, AMPK can
be activated by physiological conditions, mediated by metabolic hormones, by different cell stress
conditions, and also by pharmacological molecules [1,2]. This kinase is highly conserved in eukaryotic
species and is ubiquitously expressed. Structurally, AMPK is a heterotrimeric protein including an
alpha (α) catalytic subunit, a scaffolding beta (β), and regulatory gamma (γ) subunits, which are
encoded by seven genes, allowing the formation of different heterotrimer combinations of α, β, and γ
isoforms of AMPK (Figure 1).
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Figure 1. Structure of AMP-activated kinase (AMPK). AMPK is a heterotrimeric protein with 3 
differents subunits: catalytic α (blue), scaffolding β (green) and regulatory γ (yelow), each one can be 
expressed as different isoforms, enabling distinct heterotrimeric combinations of AMPK. Regulatory 
subunit γ controls the activity of the α subunit through 4 tandem repeats of the motif CBS 
(cystathionine β-synthase) that bind adenosine nucleotides (AMP, ADP, ATP) with high affinity. 
AMPK remains inactive in presence of high levels of ATP, whereas during starvation or when ATP 
level decreases, CBS domains bind AMP, which favors the phosphorylation at Thr172 (catalytic α 
subunit) and subsequently leading to AMPK activation. 
Given its central regulator role in metabolism and its pleiotropic action in many cellular 
processes, AMPK has received enormous interest as a therapeutic target, and therefore, there has 
been a great effort to develop pharmacological activators. In addition, AMPK has been the focus of 
relevant works, although the majority of them have been conducted in somatic cells. However, the 
ability to preserve energy homeostasis under fluctuating extracellular nutrients or conditions that 
physiologically occur through the female reproductive tract is a necessary characteristic of 
spermatozoa. As mentioned before, the direct molecular connector between the substrate’s supply 
and energy requirement is AMPK. In 2012, two different research groups identified for the first time 
the presence of AMPK in mammalian spermatozoa [3,4]. Since then, interesting scientific efforts have 
been performed to elucidate the functions of AMPK in these male gametes in several species, 
including human, using different experimental approaches, including the use of α1AMPK knockout 
mice [3], and the pharmacological inhibitor and activators. To date, availability of AMPK inhibitors 
is very restricted and the most widely-used inhibitor of AMPK is the pyrazolopyrimidine derivate 
compound C or dorsomorphin (CC) that binds to the active site of AMPK and acts as an ATP-
competitive inhibitor [5]. Very recently, a new pyrimidine derivative, SBI-0206965, has been 
discovered as a direct AMPK inhibitor with greater potency (40 fold) and lower kinase promiscuity 
than CC [6]. Regarding AMPK activators, great effort has been performed for the last few years in the 
development of direct small molecules and also in their mechanisms of action. The classical activator 
is the 5-aminoimidazol-4-carboxamide-1-B-D-ribofuranoside (AICAR), although its therapeutic use 
is not warranted in humans because of its elevated threshold for AMPK activation [7]. The first direct 
AMPK activator available to scientists was A769662, which activates AMPK both allosterically and 
by inhibiting AMPKα Thr172 dephosphorylation through binding at the ADaM site, and displays 
high specificity for complexes containing AMPK-β1 isoforms compared to AMPK-β2 [7]. An 
exhaustive review about other AMPK activators has been recently published [7] and includes cyclic 
benzimidazole derivatives (compound 991, PF-739, and MK-8722), the compound C2, the 
iminothiazolidione PT-1 and its optimized C24, the bi-quinoline JJO-1 and dihydroxyquinoline 
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derivatives (compound 991, PF-739, and MK-8722), the compound C2, the iminothiazolidione PT-1
and its optimized C24, the bi-quinoline JJO-1 and dihydroxyquinoline MT47-100, and recently indole-
and indazole-acid-based AMPK synthetic activators, as well as two novel small activators, PXL770
and O304, which successfully completed phase I of clinical trials [7]. To date, the most clinically-used
activator of AMPK is metformin and although its action was originally thought to be mediated by
AMPK [8], likely through inhibition of AMP desaminase [9], it is currently established that many
of metformin effects are AMPK-independent [10–16]. Thus, besides effects on glucose metabolism,
metformin also directly inhibits complex I (NADH:ubiquinone oxidoreductase) of the mitochondrial
electron transport chain [17,18] with obvious consequences in cell energy production. Overall, we
believe that the modulation of AMPK activity would be an interesting tool for the future knowledge
about exact roles of AMPK in mammalian spermatozoa, as well as for development of novel protocols
for male fertility and/or sperm preservation in vitro.
In this review, we provide the current knowledge about AMPK function in spermatozoa
under physiological and different extracellular conditions. AMPK activity is involved in the
main physiological functions of mature spermatozoa, in particular in the maintenance of proper
sperm motility, the integrity of sperm membranes, and the mitochondrial membrane potential,
all of them adapted to the fluctuating medium of the female reproductive tract. Moreover, the
intracellular signaling pathways leading to AMPK activation in mammalian spermatozoa are reviewed.
We also discuss the role of AMPK in assisted reproduction techniques, particularly during semen
cryopreservation and preservation at low temperature. Finally, we reinforce the idea of AMPK as a
key signaling kinase in spermatozoa that acts as an essential connector between metabolism energy
and sperm ability to fertilize.
2. Role of AMPK in Male Gonads and Spermatogenesis
Fertility can be affected by nutrition and energy metabolism; in this sense, AMPK plays an
important role in the reproductive function, connecting, among other physiological regulators, the
hypothalamus–pituitary–gonadal axis with energy balance [19]. Germ cells production in the testis
occurs through spermatogenesis and terminates when the mature spermatozoa are released into the
lumen of the seminiferous tubules. A proper energy balance is necessary for spermatozoa production
in the testis, as well as for sperm function and quality after ejaculation. Nonetheless, only a few studies
have focused on the role of AMPK in the control of male fertility.
In 2008, Towler et al. [20] indicated that kinases related to AMPK exert physiological functions
in mammalian spermatozoa. Thereby, a shorter isoform of the tumor suppressor LKB1 (LKB1s)
was shown to be mainly expressed in haploid spermatids [20] where it plays an essential role in
spermiogenesis and in its fertilizing ability. LKB1s knockout mice have a high reduction in the number
of mature spermatozoa in the epididymis, and the few spermatozoa produced are not motile and have
abnormal head morphology, which causes sterile mice [20]. These data suggested that this variant of
the LKB1 has a crucial role in spermiogenesis and fertility in mice. A new recent study has confirmed
these results, where Kong et al. have shown that although LKB1s is the dominant isoform expressed in
mice testis and plays a crucial role in spermiogenesis, the long isoform of the tumor suppressor LKB1L
was also required [21]. This group suggests an indispensable role of LKB1L in spermatogonial stem cell
maintenance and the cooperative regulations of both LKB1 isoforms in spermatids differentiation [21].
On the other hand, deletions of TSSK1 and TSSK2, two members of testis specific TSSK family or
Ser/Thr kinases, which belong to AMPK branch in the human kinome tree, cause infertility in chimera
mice due to haploinsufficiency [22]. The above-mentioned studies point out that some AMPK-related
kinases might play a key role in the spermatozoa production and function.
Male gonadal somatic cells include Sertoli (SCs) and Leydig cells (LCs). Proliferation and survival
of somatic cells of the testis are crucial for fertility. In fact, testis size and sperm production are directly
correlated to the total number of adult Sertoli cells. These cells play a central role in spermatogenesis
by providing support and nutrition for spermatogenic cells; however, each SC nourishes a limited
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number of differentiating germ cells [23]. SCs maintain the blood–testis barrier, an essential feature
of seminiferous tubules, which creates the proper environment for the spermatogenic process to be
held [24]. It was demonstrated that maintenance of SCs cytoskeletal dynamics, polarity, and junctional
communications are essential for fertility [25], and that disorders on their apical extensions, which
direct migration of differentiating germ cells towards the lumen, leads to premature germ cell loss [26].
In 2012, Tanwar et al. showed the importance of the upstream AMPK kinase LKB1 signaling in rats
SCs biology and spermatogenesis. They demonstrated that aberrant AMPK-mTOR signaling causes
disruption of SCs polarity and spermatogenesis [27]. In the same year, Riera et al. demonstrated
that the follicle-stimulating hormone (FSH) regulates SCs proliferation with the participation of
the PI3K/Akt/mTORC1 pathway and that AMPK activation may be involved in the detention of
proliferation by, at least in part, a decrease in mTORC1 signaling and an increase in cyclin-dependent
kinase inhibitor (CDKI) expression [28]. Thus, well-coordinated AMPK-mTOR signaling is essential
for SCs functions and survival in rats [27,28]. According to a recent study, heat treatment could
reversibly perturb the expression of tight junction proteins in immature porcine SCs by inhibiting the
AMPK signaling pathway [29]. The use of the AMPK activator AICAR can affect adhesion molecule
expression and influences junction complex integrity in rat SCs, as it has been described in 2010
by Galardo et al. [30]. This group also suggested an important role of AMPK in modulating the
nutritional function of SCs. They demonstrated that AMPK stimulation with AICAR increased lactate
production and glucose transport [31]. On the other hand, the inactivation of α1AMPK in mice SCs
reduces the expression of mitochondrial markers (cytochrome c and PGC1-α) and the ATP content, and
conversely, increases the lactate production and lipid droplets [32]. Specific deletion of the α1AMPK
gene in mice SCs resulted in a 25% reduction in male fertility associated with abnormal spermatozoa
with a thin head. Testes showed no clear alterations of morphology or modification in the number
of SCs in vivo, but a deregulation in energy metabolism in SCs was observed [32]. These authors
suggested that deregulation of the energy-sensing machinery through disruption of α1AMPK in SCs
leads to a reduction in the quality of germ cells and fertility [32]. These results supported those
obtained by Tartarin et al. performed in mice, where the indirect AMPK activator metformin decreased
testosterone production in vitro and reduced the testicular size and the population of SCs in vivo [3].
The involvement of AMPK activity has also been studied in SCs under different stimuli/conditions and
from other species such as boar. Thus, Jiao et al., reported that 17β-estradiol inhibited immature boar
SCs viability and cell cycle progression by activating the AMPK signaling pathway. Furthermore, they
showed that AMPK activation by AICAR inhibited SCs viability, while the AMPK inhibitor compound
C attenuated the effects of 17β-estradiol on SCs [33]. Besides these findings in mammalian testes, it
has been reported that AMPK activity also exerts regulatory functions in avian gonads, as metformin
treatment also reduced SCs proliferation and increased lactate secretion in chickens [34].
The precise composition of the extracellular environment of germinal cells in the seminiferous
tubules remains unknown, but it is well established that SCs secrete molecules that are crucial for the
spermatogenic process [35]. In this sense, SCs secrete proteins and cytokines, which participate in the
control of spermatozoa movement from the testis to the epididymis, and in the control of the pH of the
seminiferous fluid [36]. During spermatogenesis, lactate is the preferred substrate of spermatocytes
and spermatids. Lactate production from glucose in SCs is an important point for the control of
spermatogenesis [37]. Recently, it has been demonstrated that AMPK reduces heat-induced lactate
secretion by decreasing the expression levels of the glucose transporter GLUT3, LDHA, and MCT1 [38].
This work also suggested that AMPK is a negative regulator of heat treatment-induced lactate secretion
in cultured boar SCs [38].
It has been demonstrated that AMPK is involved in the regulation of spermatozoa quality through
its action, not only on the proliferation of SCs, but also in another type of testicular somatic cells, Leydig
cells (LCs), (Figure 2) which are responsible for producing testicular androgens, such as testosterone,
for the paracrine regulation of spermatogenesis within the testis in adult life [39].
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Figure 2. AMPK functions in male gonads and spermatozoa production. AMPK activity is involved 
in the control of the male gonad function, spermatozoa production and quality by its action also on 
the male gonadal somatic cells (Sertoli and Leydig cells). 
Steroid hormones regulate essential physiological processes, thus, testosterone is also responsible 
for the differentiation and development of male reproductive organs, as well as for maintaining 
secondary sex characteristics and sexual function. Within the testis, the functions of the LCs are mainly 
controlled by the hypothalamus–pituitary axis. An α1AMPK knockout mice model has been studied by 
Tartarin et al. [3]. The male α1AMPK−/− mice have high levels of testosterone due to hyperactive LCs 
[3]. Indeed, the LCs of these animals have an increased volume, an altered endoplasmic reticulum area, 
a high intratesticular cholesterol concentration, and a greater expression of proteins involved in steroid 
production [3]. In agreement with this data, Abdou et al. identified AMPK as a molecular rheostat that 
actively represses steroid hormone biosynthesis to preserve cellular energy homeostasis and prevent 
excess steroid production in LCs [40]. Recently, the role of AMPK in steroidogenesis has also been 
investigated in vivo in ovine testis by Taibi et al. These authors report that active AMPK is expressed 
in this gonad, and more importantly, they demonstrated that AMPK activity is regulated by nutritional 
status [41]. However, to date, the expression patterns of the different AMPK isoforms in spermatozoa 
are unknown. One of the most recent studies revealed that resveratrol enhanced AMPK 
phosphorylation and may exert its cytoprotective role against oxidative injury by the activation of 
autophagy via AMPK/mTOR pathway in LCs [42]. Beside mammals, the effect of metformin has also 
been studied in avian species; thus in 6-week-old chickens, metformin induces a decrease in 
testosterone levels and reduces testis size [34]. 
To date, AMPK has also been studied in male gonads from other mammal species such as rats 
[28,43–48], mice [49–55], lambs [56], monkeys [48], and humans [57]. Taking into account all the 
aforementioned articles, it can be concluded that the AMPK pathway is involved in the control of the 
male gonad function, spermatozoa production, and quality by its action also on the male gonadal 
somatic cells and point out AMPK as a novel gatekeeper of steroidogenesis and a target for 
modulating steroid hormone production. Therefore, AMPK appears as a key signaling protein for the 
spermatozoa and male fertility control. 
3. Localization of AMPK in Mammalian Spermatozoa 
The presence of the AMPK protein in mature spermatozoa was demonstrated independently in 
2012 in two mammalian species, boar [4] and mouse [3]. Later, AMPK protein localization has been 
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3. Localization of AMPK in Mammalian Spermatozoa
The presence of the AMPK protein in mature spermatozoa was demonstrated independently in
2012 in two mammalian species, boar [4] and mouse [3]. Later, AMPK protein localization has been
confirmed in mouse cauda epididymal spermatozoa [58] and also in spermatozoa from stallions [59,60],
rats [61], and very recently, goats [62] and humans [63,64]. Immunolocalization techniques reveal that
AMPK localization in spermatozoa slightly varies between species. AMPK is localized at the entire
acrosome and in the midpiece of flagellum in boar spermatozoa [65]. Interestingly, in this species,
when AMPK becomes phosphorylated at Thr172 (active) is specifically restricted to the most apical
part of the acrosome and to the subequatorial segment, remaining in the midpiece of the flagellum [65].
In human spermatozoa, AMPK is localized at the entire acrosome, the midpiece and along the tail of
the flagellum [63,64], whereas its active form is found only at the most apical part of the acrosome
and along the entire tail, with very slight amounts in the post-acrosomal region and in the midpiece
of the flagellum [63]. In stallion spermatozoa, active AMPK is mainly detected in the subequatorial
region in the head and in the principal piece of the tail [59]. AMPK localization has also been studied
in spermatozoa from avian spermatozoa [66]. Thus, in chicken spermatozoa, AMPK is present in the
acrosome, the intermediate part, and the whole flagellum, whereas active AMPK is mainly localized in
the flagellum and the acrosome [66].
4. Functions of AMPK in Mammalian Spermatozoa
4.1. Role of AMPK in the Regulation of Spermatozoa Motility
Sperm metabolic plasticity, and particularly the capacity to switch substrates and also to respond
to stimuli, renders a transcendent adaptation to sperm extracellular medium fluctuations, which
might include exhausted energy, high-energy demand, and low oxygen availability. AMPK plays
a central role in the regulation of energy metabolism homeostasis [1,2], and therefore, this kinase
has recently emerged as a new signaling pathway that exerts a necessary control of sperm function.
The specific and primordial function of spermatozoa fertilization is highly dependent on the proper
sperm motility. Motility is a characteristic sperm functional process that is tightly regulated in response
to the spermatozoa environment and to the subsequent changes in energy demands during its transit
trough the female reproductive tract. AMPK involvement on sperm motility has been demonstrated
by different experimental approaches that were independently performed in two mammalian species,
boar [4] and mice [3]. Thus, transgenic mice lacking the catalytic subunit α1 gene (α1AMPK knockout)
have a dramatic reduction in sperm motility and curvilinear velocity [3]. Similarly, a pharmacological
approach in boar spermatozoa demonstrates that AMPK inhibition by CC significantly decreases
the percentage of motile spermatozoa, the sperm curvilinear velocity and subsequently diminishes
the percentage of rapid spermatozoa (with average velocity >80 µm/s), also affecting other motility
parameters and coefficients evaluated specifically using a computer-assisted sperm analysis system [4].
Later, the important regulatory role of AMPK in spermatozoa motility was demonstrated for other
mammalian species such as human [63,64], rat [61], stallion [60], and goat [62]. This clear role of
AMPK in sperm motility suggests that this kinase might phosphorylate downstream substrates
including proteins of the axoneme or in other related structures that are indispensable for sperm
flagellar motility, as it has been previously demonstrated for the AMPK related kinase TSSK2 [67].
Thus, sperm TSKK2 phosphorylates the axoneme protein SPAG16L (sperm associated antigen 16)
in vitro, a protein necessary for flagellar motility in mouse spermatozoa [68]. Surprisingly, by using a
specific pharmacological AMPK activator, A769662 [69], it has been shown that an increase in AMPK
activity above physiological levels also adversely influences sperm motility in two mammalian species,
boar [70] and human [71]. Therefore, it has been proposed [70,72] that either up or down fluctuations
of sperm AMPK activity (away from energy charge-regulated physiological levels) cause a negative
role in mammalian sperm motility. A range of physiological levels of AMPK activity is essential to
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accomplish optimal sperm motility (Figure 3) that must adapt to the fluctuating extracellular conditions
that spermatozoa can be physiologically exposed to [19,70,72].Int. J. Mol. Sci. 2018, 19, x FOR PEER REVIEW  7 of 24 
 
 
Figure 3. Different AMPK activity levels control spermatozoa motility. In vivo, during the 
spermatozoa transit trough the female reproductive tract, fluctuating levels of AMPK activity might 
occur in spermatozoa depending on the sperm energy demands. A physiological range of energy-
charge regulated levels of AMPK activity is essential to accomplish optimal sperm motility that is 
adapted to the fluctuating extracellular conditions within the female reproductive tract. Up or down 
fluctuations of sperm AMPK activity cause a negative role in mammalian sperm motility. 
In vivo, during the sperm transit trough the female reproductive tract, fluctuating levels of 
AMPK activity might occur in spermatozoa depending on the sperm energy demands. Whenever 
environment-depending demands of energy lead to a lower sperm AMPK activity that falls below 
the so-called physiological range, inactive AMPK is unable to adjust sperm metabolic pathways to 
control and maintain energy levels required for spermatozoa motility, which is negatively affected, 
as demonstrated in several species [3,4,62,63]. The proposal that a physiological range of AMPK 
activity is necessary for appropriate sperm motility is firmly supported by a study performed in 
transgenic mice lacking the catalytic subunit α1 gene [α1AMPK knockout (KO)] which presents a 
great reduction in sperm motility and curvilinear velocity [3]. Whenever environment-depending 
demands of energy lead to a sustained sperm AMPK activity raised above the physiological range 
(i.e., sperm stresses), the sustained AMPK activity would lead to a deregulation of sperm metabolism 
caused by a prolonged stimulation of ATP-generating catabolic pathways and by a sustained 
inhibition of ATP-consuming anabolic pathways (Figure 3). Thus, the deregulation of sperm 
metabolic pathways is not suitable to accomplish proper sperm motility under any extracellular 
conditions, as demonstrated in A769662-treated spermatozoa from boars [70] and humans [71]. In 
accordance with these findings, it has been demonstrated that spermatozoa exposure to stress stimuli, 
such as pollutants like hydrogen sulfide and/or ammonia, which lead to AMPK activation, causes a 
decline in boar spermatozoa motility [73]. In addition, this proposal is also supported by recent 
results obtained using a more physiological method of arresting the motility activation of rat caudal 
spermatozoa by isolating and lowering temperature (0–2 °C) without freezing [61]. AMPK activity in 
rat quiescent spermatozoa is higher than in motile spermatozoa [61], which supports the idea that 
AMPK is effectively regulating sperm motility by allowing these male gametes to adapt to 
extracellular-driven changes in sperm energy charge. Thus, the potent activation of AMPK in rat 
quiescent spermatozoa guarantees the most efficient pathways of energy metabolism and promotes 
their survival under a low energy-starved status with very limited energy resources [61]. Under these 
circumstances of an elevated AMPK activation, rat quiescent spermatozoa are not motile. When 
sperm substrates/stimuli become available during the initiation of sperm motility after ejaculation, 
AMPK activity levels diminish compared with quiescent spermatozoa [61], although they are still 
detectable and likely remain at the so-called physiological range of AMPK activity in rat 
3. Differ nt AMPK activity levels control spe matozoa motility. In vivo, during the spermatozoa
transit rough the female reproductive tract, fluctuating evels of AMPK activity might occur in
spermatozoa depending on the sperm energy demands. A physiological range of en rgy-charge
regulated levels of AMPK activity is essential to accomplish optimal sperm motility that is adapted to
the fluctuating extracellular conditions within the female reproductive tract. Up or down fluctuations
of sperm AMPK activity cause a negative role in mammalia sperm motility.
In vivo, during the sperm transit trough the female reproductive tract, fluctuating levels of
AMPK activity might occur in spermatozoa depending on the sperm energy demands. henever
environment-depending demands of energy lead to a lower sperm AMPK activity that falls below
the so-called physiological range, inactive AMPK is unable to adjust sperm metabolic pathways to
control and maintain energy levels required for spermatozoa motility, which is negatively affected,
as demonstrated in several species [3,4,62,63]. The proposal that a physiological range of AMPK
activity is necessary for appropriate sperm motility is firmly supported by a study performed in
transgenic mice lacking the catalytic subunit α1 gene [α1AMPK knockout (KO)] which presents a great
reduction in sperm motility and curvilinear velocity [3]. Whenever environment-depending demands
of energy lead to a sustained sperm AMPK activity raised above the physiological range (i.e., sperm
stresses), the sustained AMPK activity would lead to a deregulation of sperm metabolism caused
by a prolonged stimulation of ATP-generating catabolic pathways and by a sustained inhibition of
ATP-consuming anabolic pathways (Figure 3). Thus, the deregulation of sperm metabolic pathways is
not suitable to accomplish proper sperm motility under any extracellular conditions, as demonstrated
in A769662-treated spermatozoa from boars [70] and humans [71]. In accordance with these findings,
it has been demonstrated that spermatozoa exposure to stress stimuli, such as pollutants like hydrogen
sulfide and/or ammonia, which lead to AMPK activation, causes a decline in boar spermatozoa
motility [73]. In addition, this proposal is also supported by recent results obtained using a more
physiological method of arresting the motility activation of rat caudal spermatozoa by isolating and
lowering temperature (0–2 ◦C) without freezing [61]. AMPK activity in rat quiescent spermatozoa is
higher than in motile spermatozoa [61], which supports the idea that AMPK is effectively regulating
sperm motility by allowing these male gametes to adapt to extracellular-driven changes in sperm
energy charge. Thus, the potent activation of AMPK in rat quiescent spermatozoa guarantees the most
efficient pathways of energy metabolis and promotes their survival under a low energy-starved
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status with very limited energy resources [61]. Under these circumstances of an elevated AMPK
activation, rat quiescent spermatozoa are not motile. When sperm substrates/stimuli become available
during the initiation of sperm motility after ejaculation, AMPK activity levels diminish compared
with quiescent spermatozoa [61], although they are still detectable and likely remain at the so-called
physiological range of AMPK activity in rat spermatozoa. This female tract environment-driven shift
in AMPK activity to a physiological level is necessary to adjust the proper sperm motility under these
new requirements in energy demand [61].
However, very recently, one study found that other AMPK activators, such as AICAR and
metformin, improve progressive motility in goat spermatozoa [62]. It is important to mention several
arguments that might account for the different results found in this species: (a) The increase in
phospho-AMPK levels obtained by AICAR and metformin in goat spermatozoa is very slight [62]
compared with the high AMPK activity levels observed in boar [70] or rat [61] that lead to inhibition
of sperm motility. Moreover, these two activators, AICAR and metformin, fail to activate AMPK
in spermatozoa from other species such boar [70], where only A769662 was found to be effective
activating AMPK. In addition, metformin also fails to effectively increase AMPK phosphorylation in
human spermatozoa [71]. (b) It is reasonable to assume that besides great differences in the intensity of
AMPK activation and the differences attributable to spermatozoa from distinct species, the specificity
and effectiveness of each pharmacological activator should be kept in mind, also for further studies.
This review tries to summarize the current knowledge about the role of AMPK activity in the regulation
of sperm motility, and it seems clear that future research in this area is needed to elucidate the exact
molecular mechanism by which AMPK exerts this regulation in sperm cells and also to discover AMPK
protein substrates that belong to the intracellular signaling pathways controlling sperm motility.
4.2. Role of AMPK in the Regulation of Spermatozoa Mitochondrial Activity
As an energy regulator protein, AMPK has additionally been pointed out as important
pathway that contributes to the maintenance of the mitochondrial membrane potential (∆Ψm) in
spermatozoa [3,65]. Different experimental approaches designed to inactivate sperm AMPK cause a
decrease in sperm ∆Ψm in different species: goat [62], boar [65], stallion [60], and α1AMPK knockout
mouse [3]. Besides a fall (50%) in sperm ∆Ψm, α1AMPK knockout (KO) mice exhibited a lower number
of mitochondria and had a significant lower consumption (60%) of basal oxygen [3]. Furthermore, a
short up-activation of sperm AMPK using A769662 prevents the decrease in the number of Ca2+ and
bicarbonate-stimulated spermatozoa presenting high ∆Ψm in boar [70], whereas it has no significant
effect in ∆Ψm of human spermatozoa [71]. However, the indirect activator of AMPK resveratrol
significantly increased ∆Ψm in frozen–thawed human spermatozoa [64]. In mouse fresh spermatozoa,
another indirect activator of AMPK metformin causes a concentration-dependent decrease of ∆Ψm [74].
Thus, AMPK activity seems to be involved in the regulation of sperm ∆Ψm, although there are
differences between species, the (direct or indirect) pharmacological compound used to activate
AMPK and the cell status of spermatozoa (fresh or frozen–thawed). In any case, the effect of AMPK
in sperm ∆Ψm, when demonstrated, is clearly dependent on sperm extracellular stimuli [70,72],
pointing out AMPK as a metabolic checkpoint by integrating stimuli-induced signaling with sperm
metabolism [70]. Therefore, it has been proposed that AMPK activity (at specific levels) is essential
to maintain sperm mitochondrial membrane potential [70,72]. Thus, AMPK contributes to modulate
the mitochondrial membrane potential according to extracellular stimuli or conditions-derived sperm
energy, and subsequently promotes the proper sperm motility, at least in some species. The involvement
of AMPK in the modulation of sperm ∆Ψm is further supported by the localization of important
amounts of active AMPK (Thr172 phosphorylated) at the midpiece of mammalian spermatozoa where
mitochondria are located, as it has been demonstrated in boar [65], goats [62], stallions [60], and
humans [63].
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4.3. Role of AMPK in the Regulation of Spermatozoa Membranes
Mammalian spermatozoa need a tight modulation of energy also to maintain cellular structure,
stability, and physiology of membranes during fluctuating extracellular conditions within the female
reproductive tract that ultimately allow them oocyte fertilization [75,76]. An important factor that
contributes to the correct function of spermatozoa is the degree of lipid organization of their plasma
membrane. In fact, the energy charge-sensor kinase AMPK plays a role in the maintenance of sperm
plasma membrane fluidity and lipid organization as it has been demonstrated in some species such
as boar [65] and goat [62]. Thus, experiments using either an AMPK inhibitor (CC) in boar [65]
and goat spermatozoa [62], or the activator A769662, demonstrated a significant increase in plasma
membrane lipid disorganization [70]. Importantly, this effect of AMPK is clearly dependent of the
stimuli present in the extracellular medium, as sperm plasma membrane disorganization is ≈3-fold
higher when boar spermatozoa are incubated in the presence of capacitating stimuli (Ca2+, bicarbonate,
and serum albumin) than in a stimuli-free medium [65]. All together, these findings suggest that
specific physiological levels of AMPK play a regulatory role in the preservation of the proper lipid
organization and fluidity in sperm plasma membrane according to extracellular stimuli [65,77].
Furthermore, physiological levels of bicarbonate cause a quick collapse of the asymmetry of the
sperm plasma membrane attributable to the scramblases activation, which translocate phospholipids
such as phosphatidylethanolamine and phosphatidylserine (PS) outward of plasma membrane [78].
The PS externalization evidences plasma membrane scrambling which physiologically takes place in
important sperm processes. Interestingly, AMPK inhibition in spermatozoa incubated in the presence
of bicarbonate result in a significant inhibition of the outward exposure of PS in plasma membrane,
suggesting that inhibition of AMPK, at least over a short time (4 h), could be causing a downstream
inhibition of scramblases activity [65]. Moreover, an enhanced AMPK activity (for 24 h) induces a
significant PS externalization in boar sperm plasma membrane [70]. These functional consequences of
AMPK in boar sperm plasma membrane, which are lipid disorganization and the PS translocation, are
presumably taking place at the plasma membrane surrounding the most apical acrosome region, where
most of active phospho-Thr172 AMPK is restricted in this specie [65]. The involvement of AMPK in
boar sperm membranes organization is supported by the finding that AMPK is downstream of the
cAMP/PKA pathway [79], which is an essential regulatory pathway for the lipid architecture of the
sperm plasma membrane [80,81].
Besides the regulatory role at the sperm plasma membrane, AMPK also regulates acrosome
membrane integrity under capacitating conditions [65], which is additionally supported by the fact that
high levels of active phospho-Thr172-AMPK are situated at this part of acrosome under physiological
conditions [65]. By using different experimental approaches it has been demonstrated that any
oscillation either up (A769662) or down (CC) of the AMPK activity outside of physiological levels
lead to a loss of the outer acrosome membrane integrity [65,70]. In summary, physiological sperm
AMPK activity is also essential to keep the integrity of acrosome membrane at a level suitable to the
fluctuating extracellular conditions at which spermatozoa are physiologically exposed.
4.4. Role of AMPK in the Regulation of Spermatozoa Acrosome Reaction
Mammalian spermatozoa need to acquire the ability to reach the oocyte, penetrate the
cumulus oophorus, and to bind to the zone pellucida of the oocyte, which subsequently triggers
the acrosome reaction that leads to egg fertilization [76]. The acquisition of these spermatozoa
functional competences occurs through important physiological and biochemical modifications that
are collectively named sperm capacitation. Spermatozoa processes that necessarily must occur during
capacitation are dependent on the energy levels of this gamete [82,83]. Therefore, it might be reasonable
to assume that the energy charge-sensitive AMPK should be somehow involved in the acquisition of
these sperm processes, although to date, few works have considered this issue. In fact, the activity of the
energy charge-sensitive AMPK is regulated under capacitating conditions (including Ca2+, bicarbonate,
and serum albumin) in boar spermatozoa [65]. The inhibition of AMPK activity significantly reduces
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the integrity of the acrosomal membrane in a boar sperm-capacitating medium, whereas it has no
effect in a stimuli-free medium [65]. These results indicate that AMPK is involved in the regulation of
sperm events that take place at acrosome membrane during capacitation, at least in boar spermatozoa.
However, although AMPK contributes to the maintenance of acrosome membrane integrity, is not
likely involved in the sperm process of acrosome reaction, as the inhibition of AMPK in capacitated
boar spermatozoa did not affect the acrosome reaction triggered by the calcium ionophore A23187 [65].
This lack of effect of AMPK activity in the acrosome reaction has been demonstrated also in fresh mouse
spermatozoa using the indirect activator of AMPK metformin [74]. Moreover, AMPK up-activation
does not affect the integrity of the sperm acrosome membrane. Thus, it has been demonstrated that the
activator A769662 has no measurable effect in the integrity of the acrosome membrane in human [71]
or boar spermatozoa, independently of stimuli present in the medium [79]. However, the effect of
A769662 in boar seems to be dependent on the stimulation time as a sustained AMPK activity over
24 h causes a significant loss of outer acrosome membrane integrity [79]. In contrast to mammals, few
works performed in avian sperm show that AMPK activity plays a role in the acrosome reaction [66,84].
These differences between mammals and avian spermatozoa highlight the importance of further
research about the functional role of AMPK in the acrosome reaction. To date, it can be concluded
that in parallel to modulate physiological changes (lipids organization) that occurs at the mammalian
plasma membrane during the sperm capacitation, AMPK activity contributes to the maintenance of the
outer acrosome membrane integrity, where a majority of phospho-Thr172-AMPK active is localized at
physiological conditions [4].
5. Signaling Pathways Leading to AMPK Activation in Spermatozoa
The function of AMPK as a key regulatory molecule of the essential processes that contribute to
the spermatozoa function of fertilization has been reviewed above. Therefore, an important issue in
spermatozoa physiology is to elucidate the signaling pathways leading to AMPK activity (Figure 4).
Several works using different experimental approaches demonstrate that soluble adenylate cyclase
(sAC), cAMP [4], and cAMP-dependent protein kinase (PKA)-mediated pathway lie upstream of
AMPK activity in boar spermatozoa [65,79].
The sperm cAMP/PKA pathway might promote AMPK activation through its upstream kinase
LKB1, as it occurs in somatic cells [85], where it is reported that LKB1 can be directly phosphorylated
at Ser431 by PKA in response to activation of adenylate cyclase by forskolin [86,87] or IBMX [86]. It has
been demonstrated that the short splice variant of LKB1S is highly expressed in haploid spermatids
in mice testis [20], where it is critically involved in spermiogenesis and fertility [88]. The knocking
out LKB1S in male mice causes important reproductive consequences: sterility, a marked decrease in
the number of mature spermatozoa, spermatozoa showing an abnormal head morphology, and are
non-motile. An increase in cAMP concentration might also lead to AMPK activation trough cAMP
degradation to AMP by phosphodiesterases, as occurs in somatic cells [89]. Thus, any sperm stimulus
that increases intracellular cAMP levels could promote AMPK activation either (i) by direct (allosteric)
activation of PKA, or (ii) by indirect activity of phosphodiesterases, which increase AMP levels that
allosterically activate AMPK, or (iii) by both pathways.
The intracellular messenger Ca2+ is also an essential regulator of spermatozoa functional processes.
Intracellular Ca2+ activates the specific sperm sAC and its downstream signaling through PKA,
therefore potently activates AMPK in boar spermatozoa under physiological conditions [65,79].
However, spermatozoa from the same species under conditions considered high extracellular Ca2+
concentrations (>3 mM), sperm AMPK phosphorylation decreases [90]. The involvement of Ca2+ as
an upstream regulator of AMPK activity has also been demonstrated in avian spermatozoa, as Ca2+
entry via store-operated Ca2+ channel (SOC) activates AMPK [84]. Moreover, Ca2+ can also lead to the
activation of boar sperm AMPK through the activation of Ca2+-calmodulin dependent kinase kinases
II and CaMKKα/β as demonstrated in spermatozoa from boar [79] or chicken [91], which lie upstream
of AMPK in somatic cells [92,93].
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Sperm AMPK phosphorylation is also stimulated by direct activation of PKC with phorbol
12-myristate 13-acetate (PMA), whereas the PKC inhibitor Ro-32-0432 inhibits HCO3− and
Ca2+-induced AMPK activation in boar spermatozoa [79]. These findings indicate that at least
one isoform of PKC is upstream of sperm AMPK. Several isoforms of PKC have been identified
in mammalian spermatozoa: PKCα and PKCβI in bovines [94], PKC-zeta in hamsters [95], and mouse
spermatozoa [96]. It is therefore plausible that some of these PKC isoforms might exert in spermatozoa
a similar function than in somatic cells by phosphorylating LKB1 and subsequently leading to AMPK
activation. Thus, it has been demonstrated that PKC-zeta phosphorylates LKB1 at Ser 307 [97] and
PKCζ phosphorylates LKB1 at Ser 399 [98]. An alternative explanation describing the pathway by
which PKC is upstream of sperm AMPK activity is based on the fact that PKC activity lies downstream
of PKA in the control pathway of boar sperm motility [99]. Previously, Harayama and Miyake (2006)
demonstrated that cAMP/PKA signaling can induce the activation of calcium-sensitive PKCs, which
are responsible for boar sperm hyperactivation [100]. Thus, it is proposed that another PKC isoform(s)
besides PKC-zeta, which is not calcium sensitive, could likely be involved in AMPK activation, at least
in response to an elevation of cAMP levels in boar spermatozoa [79].
In addition to the mentioned physiological mimicking conditions, AMPK becomes markedly
activated in boar spermatozoa under different stimuli considered to be cell stress (Figure 1), such
as inhibition of spermatozoa mitochondrial activity by blocking electron transport chain and
sorbitol-induced hyperosmotic stress [79]. In somatic cells, cell stress-induced AMPK activation can be
mediated by (i) an increase in AMP levels, and/or (ii) reactive oxygen species ROS generation that act
as signaling molecules to activate AMPK [101] through LKB1 and CaMKKs pathways. Surprisingly,
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the incubation with the intracellular calcium chelator BAPTA-AM in a Ca2+-free medium leads to a
strong increase in AMPK activity [79], which may be mediated through an increase in nitric oxide NO·
production. In this sense, de Lamirande et al. (2009) demonstrated in human sperm that BAPTA-AM
promotes the production of a reactive oxygen specie, the nitric oxide NO· [102]. Accordingly, AMPK
activation is also directly influenced by cellular redox status in somatic cells, as H2O2 activates AMPK
through oxidative modification of cysteine residues in the AMPKα subunit [103]. An alternative or
simultaneous explanation is that NO· produced by BAPTA-AM in boar spermatozoa might interacts
with the cAMP pathway, as it occurs in human [102], leading to AMPK activity.
Moreover, other different types of stimuli that activate AMPK in mammalian spermatozoa
have recently been described. Thus, pharmacological compounds, such as the anti-diabetic drug
rosiglitazone, increase AMPK phosphorylation in stallions [60]. Also, some toxicant compounds that
cause a marked reduction in sperm motility, such as the heavy metal cadmium, a major environmental
toxicant, affected AMPK activity in mouse spermatozoa [104], or the air pollutants hydrogen sulfide
and ammonia that activated AMPK activity in boar spermatozoa [73]. Additionally, the common
natural mycotoxin ochratoxin A triggers AMPK activation to cause a clear decrease in boar sperm
motility [105]. Based on all above-mentioned works, the exact molecular mechanisms involved in
the signaling pathway(s) triggered by a variety of stimuli that lead to AMPK activity as well as the
identity of AMPK downstream targets that ultimately control sperm function, undoubtedly deserve
future investigations.
6. Role of AMPK during Assisted Reproduction Techniques: Semen Preservation
Assisted reproduction techniques (ART) include a wide range of technologies used to improve
the chances to achieve pregnancy after the collection and handling of oocytes, sperm, and embryos
in in vitro conditions. Nowadays, around 1.5 million human ART cycles are performed each year
worldwide, with a reported 333,000 babies born. Data from human spermiograms show a decrease of
sperm quality in the last decades [106–108], and as a consequence, an increase of the use of ART, such
as intracytoplasmatic sperm injection (ICSI), sperm cryopreservation, in vitro fertilization (IVF), or the
use of spermatozoa from testicle biopsies are the most commonly used ART. In the animal field, the
use of ART is mostly aimed to quickly spread genetic material of selected animal to preserve gametes
from endangered species, also to reduce disease transmission risk or to increase animal breading. This
current and future reality leads to an increasing ART use and develop of new technical strategies to
overcome fertility problems.
6.1. Why AMPK Protein Is Important in ART?
As mentioned before, sperm capacitation is a mandatory process to fertilize oocytes and the events
related with sperm capacitation (i.e.,: hypermotility, acrosome reaction, protein phosphorylation, etc.)
consume large amounts of energy (ATP). It was also stated that AMPK acts as an energy sensor and it is
activated under physiological and/or stressful sperm conditions. Therefore, there is a growing interest
in this kinase to improve ART procedures where gametes are handled and subjected to different types
of stress such as mechanical (centrifugation, pipetting), changes in temperature, levels of CO2 and O2,
medium composition, extracellular matrix (solids, plastics), or to light exposure [109] (Figure 5).
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6.2. AMPK as a Tool to Improve ART
The sector of animal farm is very interested in ART since livestock genetic background can be
easily and successfully improved by the use of these techniques. Artificial Insemination (AI) was
the first widely accepted ART for livestock. This technology allows genetically superior males to
produce more offspring than it would be possible through conventional mating. More than 90% of
western Europe’s pig industry performs AI using boar seminal doses preserved at 17 ◦C as a routine
technique [110]. The temperature decrease during this type of preservation is aimed to reduce sperm
metabolism, which subsequently leads to lower rates of both acidification and reactive oxygen species
(ROS) production in the storage extender, both derived from accumulation of CO2 and lactic acid from
oxidative phosphorylation and glycolysis respectively, obtaining the so called “quiescent spermatozoa”.
Based on the principle that AMPK acts as a stress and energy regulator, it was reported that AMPK
becomes activated when quiescent rat spermatozoa are subjected to decreasing temperatures down
to 4 ◦C [61]. Several works have studied AMPK with the aim to improve ART when spermatozoa
are stored under non-physiological temperature during semen preservation techniques. A study
about boar seminal doses conservation at a non-physiological temperature (17 ◦C), demonstrated that
before semen preservation (day 0), sperm AMPK phosphorylation was undetectable but sperm AMPK
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activity increased during the following days of preservation, reaching a maximum phosphorylation
at day 7 [77]. Therefore, during semen preservation at 17 ◦C, at least in boar spermatozoa, the
activity of AMPK fluctuates according to extracellular conditions that include stress, and is tightly
regulated during the conservation period. This AMPK activation could be associated with a decrease
of intracellular ATP levels described during boar sperm conservation [111,112]. Effects of different
pharmacological drugs that influence AMPK activity (anti-diabetic compounds, such as metformin
and rosiglitazone, or the inhibitor CC) during semen preservation, have been studied in different
species [60,77,113]. In boar spermatozoa, only the percentage of motile spermatozoa was improved
after a short preservation period (<4 days) when compound C was added to the extender [77]. However,
other beneficial effects in semen quality were not found with the addition of CC [77] or metformin [113]
to the boar semen preservation media. Both pharmacological approaches (metformin and CC) used
during boar sperm conservation for 10 days cause similar negative effects: a reduction of sperm motility
and lower mitochondria membrane potential [77,113]. Therefore, as mentioned before, any alteration
of AMPK activity away from physiological levels during semen preservation leads to a detrimental
effect on the main sperm functions [72,77]. These results in boar have been supported by a recent work
in equine spermatozoa where compound C had a detrimental effect by decreasing sperm motility [60].
However, incubation of equine spermatozoa at physiological temperature with rosiglitazone, another
antidiabetic compound that activates AMPK [114], increases the percentages of motile and rapid
spermatozoa [60]. These authors suggest that rosiglitazone either protects and enhances mitochondria
metabolism or induces a shift in stallion spermatozoa to a glycolytic metabolism (glucose uptake is
increased), subsequently decreasing ROS and increasing intracellular ATP levels [60]. These positive
effects in sperm motility led to authors to test rosiglitazone effect on stallion seminal doses preserved
at 24 ◦C and results showed an improvement of equine sperm motility, suggesting its addition to
stallion extender during preservation [60].
Sperm cryopreservation is other ART widely used that allows preserved indefinitely spermatozoa.
Nevertheless, this procedure is harmful to the cells causing mainly structural damages to sperm
membrane, DNA fragmentation and metabolic changes that restrict its fertilization chances [115].
These deleterious effects during cryopreservation are caused by cold shock, intracellular ice formation,
oxidative stress, hypertonic damage, and combinations of these and others stressful conditions [115].
Many studies have tried to improve male gamete cryopreservation by adding antioxidants to the
semen extender to reduce oxidative stress [116]. In this regard, the natural compound resveratrol that
activates AMPK in some somatic cell types, when added to cryopreservation media, had positive effects
on human spermatozoa [64,117]. Thus, AMPK was activated and ROS levels were reduced in human
spermatozoa cryopreserved in the presence of resveratrol [64]. Moreover, DNA damage on human
cryopreserved spermatozoa was ameliorated when resveratrol was added before cryopreservation,
likely mediated by AMPK [117]. However, when resveratrol was added to boar seminal doses
preserved at 17 ◦C, no improvement was detected in any quality sperm parameter analyzed, and
negative effects were reported in mitochondria membrane potential, intracellular ATP content and
motility [118]. Thus, the possible beneficial effects of resveratrol during semen preservation seem
to be dependent on the species studied or the preservation protocol, where different actions of
resveratrol might preponderate depending of the temperature, i.e., at −196 ◦C, the scavenging
capacity preponderates, while at 17 ◦C, resveratrol negative actions might be due to Ca2+ mobilization
over time. Besides mammalian spermatozoa, the effects of the classical AMPK activator AICAR
or the indirect activator metformin were studied in avian spermatozoa. Thus, chicken spermatozoa
cryopreserved in the presence of AICAR or metformin had stimulated sperm anti-oxidative defenses by
partially restoring superoxide dismutase, glutathione peroxidase, and glutathione reductase activities,
which subsequently decreased ROS levels and lipid peroxidation, leading to an improved sperm
cryopreserved quality [119]. Also, in order to decrease oxidative stress, metformin was added (5 to
5000 µM) before mouse spermatozoa cryopreservation [74]. Although only the higher concentration of
metformin activated AMPK, any concentration tested doubled sperm survival, motility, and percentage
Int. J. Mol. Sci. 2018, 19, 3293 15 of 24
of motile spermatozoa, as well as the fertilization rate and embryo development without any reduction
in membrane lipid peroxidation [74]. These results observed in mice are surprising since it is assumed
that mitochondria is the major cellular target of metformin that leads to an inhibition of mitochondrial
respiration [120]. In fact, boar spermatozoa preserved at 17 ◦C in the presence of metformin effectively
had lower mitochondria membrane potential and also inhibited sperm motility [113]. Interestingly, the
quality of cryopreserved stallion spermatozoa was not improved when AMPK activity was modified
by any drugs tested: CC, AICAR, or metformin [59]. No significant improvement was observed in
stallion sperm survival, total motility, progressive motility or live sperm with a structurally intact
acrosome [59].
In general, the effects of the manipulation (up or down) of AMPK activity during ART protocols
seem contradictory and are basically dependent on the pharmacological agent, species, and/or the
ART protocol studied. As an example, whereas resveratrol did not have any positive effect during
boar spermatozoa preservation at 17 ◦C [118], positive effects were described in cryopreserved
human spermatozoa [64,117]. While metformin did not have any positive effect during stallion
spermatozoa cryopreservation [59], very positive outcomes were described for cryopreserved mouse
spermatozoa [74]. Moreover, it should be kept in mind that the effects of the different AMPK activators
in spermatozoa from the same species vary according to the ART used. For instance, AICAR or
metformin do not exert any beneficial effect in stallion spermatozoa cryopreserved for a long period
of time at −196 ◦C [59], whereas the indirect activator rosiglitazone has some positive actions when
spermatozoa are preserved a room temperature [60]. Therefore, we cautiously suggest that experiments
designed with pharmacological agents that act through modification of sperm AMPK activity should
be performed in each particular animal species and also under each specific conditions of ART used in
order to address stress-associated problems originated by ART protocols and that ultimately lead to a
decrease in sperm quality.
Effects of the AMPK inhibitor CC supplementation to sperm conservation media during ART
protocols are described in Table 1.
Table 1. Effects of the use of AMPK inhibitor C (compound C) in spermatozoa functions of several
species during Assisted Reproduction Techniques (ART).
Specie ART/Stress Sperm Effects Reference
Boar Preserved (17 ◦C)
1. At short period (<4 days): Improves the % of motile sperm
2. At long period (≥4 days):
Decreases sperm MMP
Decreases acrosome membrane integrity
Increases plasma membrane disorganization
[77]
Stallion Cryopreserved (−196 ◦C) No effect described [59]
Chicken Cryopreserved (−196 ◦C) Decreases motility and antioxidant capacity [119]
Stallion Preserved (RT) Reduces sperm motility [60]
Human Cryopreserved (−196 ◦C) Deleterious effect in sperm motility and mitochondriaIncreases apoptotic-like spermatozoa [64]
As expected, negative effects were found in spermatozoa when the AMPK pathway is inhibited
by CC such as reduced mitochondrial membrane potential (by 50%) and basal oxygen consumption
(by 60%) in AMPKα1 knock out mice [3], and detrimental effects on important sperm functions in
refrigerated boar spermatozoa [77], human cryopreserved spermatozoa [64], chicken cryopreserved
spermatozoa [119], or room temperature preserved stallion spermatozoa [60]. These negative effects
can be summarized as: (i) decrease of mitochondrial membrane potential; (ii) sperm motility inhibition;
(iii) loss of acrosomal membrane integrity; (iv) increase of plasma membrane disorganization; and
(v) increase of apoptotic-like spermatozoa (Table 1).
Nevertheless, although differences were observed between species and depending on the ART
used, in general, beneficial effects were found when AMPK was shown to be over-activated by
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metformin in cryopreserved mouse spermatozoa [74], rosiglitazone in stallion spermatozoa preserved
at room temperature [60], AICAR in cryopreserved chicken spermatozoa [119] and resveratrol in
cryopreserved human spermatozoa [64,117]. The positive effects observed were: (i) improvement of
sperm survival, motility, and velocity; (ii) improvement of sperm antioxidant defense and decrease of
lipid peroxidation (LPO); and (iii) improvement of embryo quality (Table 2).
Table 2. Demonstrated effects of direct (AICAR) or indirect AMPK activators (resveratrol, metformin
and rosiglitazone) in the spermatozoa functions of different species during Assisted Reproduction
Techniques (ART). Cryopreservation was always at−196 ◦C. * It has not been showed that the indicated
compound effectively activates AMPK in spermatozoa from the indicated specie.
Compound Specie ART/Stress Sperm Effects Ref.
Resveratrol * Boar Preserved (17 ◦C) Decreases sperm motility, MMP and ATP [118]
Metformin * Stallion Cryopreserved No effect described [59]
AICAR * Stallion Cryopreserved No effect described [59]
Metformin Mouse Cryopreserved Increases sperm motility and viabilityIncreases fertility rate and quality of embryos [74]
AICAR Chicken Cryopreserved Protects against ROS and lipid peroxidationImproves motility and % rapid spermatozoa [119]
Metformin Chicken Cryopreserved Protects against ROS and lipid peroxidationImproves motility and % rapid spermatozoa [119]
Rosiglitazone Stallion Preserved (RT)
Improves % motile and % rapid spermatozoa
Shifts to glycolytic metabolism, increases glucose
uptake and reduces ROS
[60]
Resveratrol Human Cryopreserved Reduces ROS and apoptosis-like spermatozoa [64]
Resveratrol Human Cryopreserved Protects against apoptotic-like spermatozoa andMMP damage [117]
Metformin * Boar Preserved (17 ◦C) Reduces sperm motility and MMP [113]
However, this issue seems controversial, as negative effects have also been demonstrated, at least
regarding metformin supplementation. Thus, sperm motility and mitochondrial membrane potential
are negatively affected in boar spermatozoa preserved at 17 ◦C in the presence of metformin [113].
Above all, AMPK protein should be considered a suitable target to effectively improve assisted
reproduction technologies’ outcomes where spermatozoa are subjected to different types of stress.
7. AMPK in Spermatozoa: A Physiological Link between Fertility and Energy Metabolism
The central role of AMPK in energy metabolism is well known, although its involvement in
fertility control has only recently been pointed out. AMPK is present in female and male gonads
and seems to contribute to the different stages of maturation of germ cells and spermatozoa by
modulating hormone production (steroidogenesis) and their interaction with nourishing gonadal
somatic cells. In mature mammalian spermatozoa, the ability to preserve energy homeostasis under
fluctuating extracellular nutrients, physiological stimuli, or even stress conditions that occur through
the female reproductive tract is a necessary characteristic of successful spermatozoa. Moreover, the
energy charge-sensitive kinase, AMPK, performs an important and essential regulator of the main
physiological processes of spermatozoa and therefore represents a proper target to improve assisted
reproduction technologies. The increasing scientific evidence about AMPK in the male fertility area
points out AMPK as the physiological link between reproduction and energy metabolism.
Moreover, considerable progress has been performed recently in the molecular development
of direct AMPK activators/inhibitors. A future scientific challenge will be to integrate some of
these promising therapeutic compounds derived from pre-clinical animal studies into practical
improvements in the field of assisted reproduction in animals and human.
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